GlaxoSmithKline is one of the biggest pharmaceutical companies in the world. Established in 2000 following the merger of Glaxo Wellcome and SmithKline Beecham, the company has grown to become a force to reckon within the industry. However, the company’s history dates back to 1873 when Glaxo Wellcome came into being, as a company focused on the production of dried milk baby foods.
The company has since evolved and seen its core business expand to the creation, development manufacture, and marketing of medicines, vaccines, and other healthcare-related products. The company operates under four main segments of pharmaceuticals, vaccines, pharmaceutical R&D, and consumer healthcare.
Some of its flagship products include Advaim Avodart and Lovaza. It is also the owner of the first-ever malaria vaccine.
While the company boasts of primary listing in the London Stock Exchange, the stock is also listed in the New York Stock Exchange.